Skip to main content
logo
Genmab A/S (CPH:GMAB)
Denmark flag Denmark · Delayed Price · Currency is DKK
1,854.50
+20.00 (1.09%)
Feb 27, 2026, 3:41 PM CET

Genmab Revenue

In the year 2025, Genmab had annual revenue of $3.72B USD with 19.19% growth. Genmab had revenue of $1.06B in the quarter ending December 31, 2025, with 3.03% growth.

Revenue
$3.72B
Revenue Growth
+19.19%
P/S Ratio
4.77
Revenue / Employee
$1.25M
Employees
2,973
Market Cap
112.95B DKK

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.72B599.00M19.19%
Dec 31, 20243.12B731.00M30.59%
Jan 1, 20242.39B305.95M14.68%
Dec 31, 20222.08B796.62M61.88%
Dec 31, 20211.29B-374.23M-22.52%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Novo Nordisk309.06B
Coloplast27.89B
H. Lundbeck24.63B
Demant22.97B
GN Store Nord16.78B
Zealand Pharma9.21B
Bavarian Nordic6.89B
ALK-Abelló6.31B
Revenue Rankings

Genmab News

More News